Multiple transcription initiation and alternative splicing in the 5′ untranslated region of the core 2 β1-6 N-acetylglucosaminyltransferase I gene

V. Rebecca Falkenberg, Karen Alvarez, Clara Roman, Nevis L. Fregien

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The glycosyltransferase core 2 β1,6 N-acetylglucosaminyltransferase I (C2GnT I) plays an important regulatory role in the synthesis of biologically significant oligosaccharide structures. This gene is expressed in a variety of cell types, including lymphocytes and mucin-producing cells. The expression pattern of this gene suggests a complex system of regulation. To investigate the molecular regulation of this gene and locate potential promoter elements, rapid amplification of cDNA ends (RACE) analysis was used to determine the 5′ ends of the C2GnT I mRNAs from a number of tissues. These experiments identified five C2GnT I mRNAs that are different in their 5′ untranslated regions. The RACE cDNAs had four different 5′ terminal sequences (exons A, B, D, and E'), suggesting four transcription initiation sites. One mRNA form was the result of alternative exon (exon C) utilization. These exons are spread across 60 kb of DNA on human chromosome 9, and all splice to the exon (exon F) that contains the C2GnT I coding region. Reverse transcription polymerase chain reaction experiments using primers specific for each of the four 5′ end exon sequences revealed that the 5′ terminal exons are differentially expressed, suggesting tissue specificity for the different 5′ untranslated regions. These findings are consistent with the presence of multiple tissue-specific promoters for the C2GnT I gene.

Original languageEnglish
Pages (from-to)411-418
Number of pages8
JournalGlycobiology
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

5' Untranslated Regions
Alternative Splicing
Transcription
Exons
Genes
Complementary DNA
Tissue
Messenger RNA
Amplification
Glycosyltransferases
Chromosomes, Human, Pair 9
Organ Specificity
Lymphocytes
alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I
Transcription Initiation Site
Polymerase chain reaction
Human Chromosomes
Mucins
Chromosomes
Oligosaccharides

Keywords

  • 5′ untranslated region
  • Alternative splicing
  • Glycosyltransferase
  • mRNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Multiple transcription initiation and alternative splicing in the 5′ untranslated region of the core 2 β1-6 N-acetylglucosaminyltransferase I gene. / Falkenberg, V. Rebecca; Alvarez, Karen; Roman, Clara; Fregien, Nevis L.

In: Glycobiology, Vol. 13, No. 6, 01.06.2003, p. 411-418.

Research output: Contribution to journalArticle

@article{4c2d6efebb1c4c7e9ec69f13591caabc,
title = "Multiple transcription initiation and alternative splicing in the 5′ untranslated region of the core 2 β1-6 N-acetylglucosaminyltransferase I gene",
abstract = "The glycosyltransferase core 2 β1,6 N-acetylglucosaminyltransferase I (C2GnT I) plays an important regulatory role in the synthesis of biologically significant oligosaccharide structures. This gene is expressed in a variety of cell types, including lymphocytes and mucin-producing cells. The expression pattern of this gene suggests a complex system of regulation. To investigate the molecular regulation of this gene and locate potential promoter elements, rapid amplification of cDNA ends (RACE) analysis was used to determine the 5′ ends of the C2GnT I mRNAs from a number of tissues. These experiments identified five C2GnT I mRNAs that are different in their 5′ untranslated regions. The RACE cDNAs had four different 5′ terminal sequences (exons A, B, D, and E'), suggesting four transcription initiation sites. One mRNA form was the result of alternative exon (exon C) utilization. These exons are spread across 60 kb of DNA on human chromosome 9, and all splice to the exon (exon F) that contains the C2GnT I coding region. Reverse transcription polymerase chain reaction experiments using primers specific for each of the four 5′ end exon sequences revealed that the 5′ terminal exons are differentially expressed, suggesting tissue specificity for the different 5′ untranslated regions. These findings are consistent with the presence of multiple tissue-specific promoters for the C2GnT I gene.",
keywords = "5′ untranslated region, Alternative splicing, Glycosyltransferase, mRNA",
author = "Falkenberg, {V. Rebecca} and Karen Alvarez and Clara Roman and Fregien, {Nevis L.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1093/glycob/cwg039",
language = "English",
volume = "13",
pages = "411--418",
journal = "Glycobiology",
issn = "0959-6658",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Multiple transcription initiation and alternative splicing in the 5′ untranslated region of the core 2 β1-6 N-acetylglucosaminyltransferase I gene

AU - Falkenberg, V. Rebecca

AU - Alvarez, Karen

AU - Roman, Clara

AU - Fregien, Nevis L.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The glycosyltransferase core 2 β1,6 N-acetylglucosaminyltransferase I (C2GnT I) plays an important regulatory role in the synthesis of biologically significant oligosaccharide structures. This gene is expressed in a variety of cell types, including lymphocytes and mucin-producing cells. The expression pattern of this gene suggests a complex system of regulation. To investigate the molecular regulation of this gene and locate potential promoter elements, rapid amplification of cDNA ends (RACE) analysis was used to determine the 5′ ends of the C2GnT I mRNAs from a number of tissues. These experiments identified five C2GnT I mRNAs that are different in their 5′ untranslated regions. The RACE cDNAs had four different 5′ terminal sequences (exons A, B, D, and E'), suggesting four transcription initiation sites. One mRNA form was the result of alternative exon (exon C) utilization. These exons are spread across 60 kb of DNA on human chromosome 9, and all splice to the exon (exon F) that contains the C2GnT I coding region. Reverse transcription polymerase chain reaction experiments using primers specific for each of the four 5′ end exon sequences revealed that the 5′ terminal exons are differentially expressed, suggesting tissue specificity for the different 5′ untranslated regions. These findings are consistent with the presence of multiple tissue-specific promoters for the C2GnT I gene.

AB - The glycosyltransferase core 2 β1,6 N-acetylglucosaminyltransferase I (C2GnT I) plays an important regulatory role in the synthesis of biologically significant oligosaccharide structures. This gene is expressed in a variety of cell types, including lymphocytes and mucin-producing cells. The expression pattern of this gene suggests a complex system of regulation. To investigate the molecular regulation of this gene and locate potential promoter elements, rapid amplification of cDNA ends (RACE) analysis was used to determine the 5′ ends of the C2GnT I mRNAs from a number of tissues. These experiments identified five C2GnT I mRNAs that are different in their 5′ untranslated regions. The RACE cDNAs had four different 5′ terminal sequences (exons A, B, D, and E'), suggesting four transcription initiation sites. One mRNA form was the result of alternative exon (exon C) utilization. These exons are spread across 60 kb of DNA on human chromosome 9, and all splice to the exon (exon F) that contains the C2GnT I coding region. Reverse transcription polymerase chain reaction experiments using primers specific for each of the four 5′ end exon sequences revealed that the 5′ terminal exons are differentially expressed, suggesting tissue specificity for the different 5′ untranslated regions. These findings are consistent with the presence of multiple tissue-specific promoters for the C2GnT I gene.

KW - 5′ untranslated region

KW - Alternative splicing

KW - Glycosyltransferase

KW - mRNA

UR - http://www.scopus.com/inward/record.url?scp=0038280004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038280004&partnerID=8YFLogxK

U2 - 10.1093/glycob/cwg039

DO - 10.1093/glycob/cwg039

M3 - Article

C2 - 12626388

AN - SCOPUS:0038280004

VL - 13

SP - 411

EP - 418

JO - Glycobiology

JF - Glycobiology

SN - 0959-6658

IS - 6

ER -